Terms ending in 2029
Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,048,881 | Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 8,058,263 | Substituted 2-Phenyl-PYRIDINE Derivatives In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 8,268,847 | Therapeutic Compositions Comprising a Specific Endothelin Receptor Antagonist and a PDE5 Inhibitor In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence | |
| US 7,872,050 | Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof In force · High confidence | Helsinn Birex Pharmaceuticals Limited | In force | High confidence | |
| US 9,173,881 | Therapeutic Compositions Containing Macitentan In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence | |
| US 9,597,331 | Therapeutic Compositions Containing Macitentan In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence | |
| US 8,324,232 | 4-Pyrimidinesulfamide Derivative In force · High confidence | Idorsia Pharmaceuticals Ltd. | In force | High confidence | |
| US 8,518,912 | Phosphonic Acid Derivates and Their Use as P2Y12 Receptor Antagonists In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US RE43,728 | THIAZOLIDIN-4-ONE Derivatives In force · Low confidence | Vanda Pharmaceuticals Inc. | In force | Low confidence |
9 of 9 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.